| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | Mar 13, 2023 | ZEVRA THERAPEUTICS, INC. | CEO | Buy | 91.3 | +10,000 | 50.07% | ✗ | $42K |
| Jan 13, 2023 | Jan 13, 2023 | ZEVRA THERAPEUTICS, INC. | CEO | Buy | 95.0 | +9,500 | 90.71% | ✗ | $51.7K |
| May 18, 2022 | May 18, 2022 | ZEVRA THERAPEUTICS, INC. | Chair | Buy | 91.3 | +5,000 | 152.21% | ✗ | $24.6K |
| Nov 30, 2021 | Nov 30, 2021 | ZEVRA THERAPEUTICS, INC. | Chair | Buy | 91.3 | +1,500 | 84.03% | ✗ | $11.8K |
| Aug 18, 2020 | Aug 18, 2020 | ZEVRA THERAPEUTICS, INC. | Director | Buy | 90.0 | +10,000 | 53.84% | ✗ | $6.4K |